Newbridge Financial Services Group, Inc. Amarin Corp Plcuk Transaction History

Newbridge Financial Services Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$0.82 - $1.35 $34,358 - $56,565	41,900 New	41,900 $37,000
Q2 2023 Jul 21, 2023	SELL	$1.12 - $1.49 $2,800 - $3,725	-2,500 Reduced 35.71%	4,500 $5,000
Q2 2022 Jul 15, 2022	BUY	$1.13 - $3.69 $2,260 - $7,380	2,000 Added 40.0%	7,000 $10,000
Q1 2022 Apr 26, 2022	BUY	$2.85 - $3.73 $8,550 - $11,190	3,000 Added 150.0%	5,000 $16,000
Q4 2021 Jan 19, 2022	SELL	$3.24 - $5.18 $4,131 - $6,604	-1,275 Reduced 38.93%	2,000 $7,000
Q3 2021 Oct 27, 2021	BUY	$3.94 - $5.84 $8,963 - $13,286	2,275 Added 227.5%	3,275 $17,000
Q1 2021 Sep 07, 2021	BUY	$5.03 - $8.8 $5,030 - $8,800	1,000 New	1,000 $6,000
Q4 2020 Sep 07, 2021	SELL	$4.04 - $5.31 $6,060 - $7,964	-1,500 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$3.64 - $7.76 $5,460 - $11,640	1,500 New	1,500 $6,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.